BRUKER CORPORATION Cost of Revenue
BRUKER CORPORATION (BRKR) reported Cost of Revenue of $422.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-05
- BRUKER CORPORATION cost of revenue for the quarter ending 2026-06-30 was $422.50M, a 3.87% decline year-over-year.
- BRUKER CORPORATION cost of revenue for the quarter ending 2026-03-31 was $443.60M, a 8.14% increase year-over-year.
- BRUKER CORPORATION cost of revenue for the quarter ending 2025-12-31 was $528.00M, a 8.57% increase year-over-year.
- BRUKER CORPORATION cost of revenue for the quarter ending 2025-09-30 was $481.10M, a 7.97% increase year-over-year.
- BRUKER CORPORATION cost of revenue for fiscal 2025 was $1.86B, a 8.26% increase from fiscal 2024.
- BRUKER CORPORATION cost of revenue for fiscal 2024 was $1.72B, a 18.31% increase from fiscal 2023.
- BRUKER CORPORATION cost of revenue for fiscal 2023 was $1.45B, a 18.47% increase from fiscal 2022.
- BRUKER CORPORATION cost of revenue for fiscal 2022 was $1.23B, a 1.38% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $422.50M 10-Q · filed 2026-08-05 | $866.10M 10-Q · filed 2026-08-05 | $1.39B derived: sum of 3 quarters · filed 2026-08-05 | $1.88B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $443.60M 10-Q · filed 2026-05-07 | $971.60M derived: sum of 2 quarters · filed 2026-05-07 | $1.45B derived: sum of 3 quarters · filed 2026-05-07 | $1.89B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $528.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.01B derived: sum of 2 quarters · filed 2026-02-27 | $1.45B derived: sum of 3 quarters · filed 2026-08-05 | $1.86B 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $481.10M 10-Q · filed 2025-11-05 | $920.60M derived: sum of 2 quarters · filed 2026-08-05 | $1.33B 10-Q · filed 2025-11-05 | $1.82B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $439.50M 10-Q · filed 2026-08-05 | $849.70M 10-Q · filed 2026-08-05 | $1.34B derived: sum of 3 quarters · filed 2026-08-05 | $1.78B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $410.20M 10-Q · filed 2026-05-07 | $896.50M derived: sum of 2 quarters · filed 2026-05-07 | $1.34B derived: sum of 3 quarters · filed 2026-05-07 | $1.76B derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $486.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $931.90M derived: sum of 2 quarters · filed 2026-02-27 | $1.35B derived: sum of 3 quarters · filed 2026-02-27 | $1.72B 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $445.60M 10-Q · filed 2025-11-05 | $861.70M derived: sum of 2 quarters · filed 2025-11-05 | $1.23B 10-Q · filed 2025-11-05 | $1.65B derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $416.10M 10-Q · filed 2025-08-06 | $785.00M 10-Q · filed 2025-08-06 | $1.21B derived: sum of 3 quarters · filed 2026-02-27 | $1.57B derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $368.90M 10-Q · filed 2025-05-07 | $793.10M derived: sum of 2 quarters · filed 2026-02-27 | $1.15B derived: sum of 3 quarters · filed 2026-02-27 | $1.49B derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $424.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $784.20M derived: sum of 2 quarters · filed 2026-02-27 | $1.13B derived: sum of 3 quarters · filed 2026-02-27 | $1.45B 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $360.00M 10-Q · filed 2024-11-07 | $701.40M derived: sum of 2 quarters · filed 2024-11-07 | $1.03B 10-Q · filed 2024-11-07 | $1.37B derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $341.40M 10-Q · filed 2024-08-09 | $667.00M 10-Q · filed 2024-08-09 | $1.01B derived: sum of 3 quarters · filed 2025-03-03 | $1.31B derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $325.60M 10-Q · filed 2024-05-10 | $668.10M derived: sum of 2 quarters · filed 2025-03-03 | $971.70M derived: sum of 3 quarters · filed 2025-03-03 | $1.26B derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $342.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $646.10M derived: sum of 2 quarters · filed 2025-03-03 | $936.30M derived: sum of 3 quarters · filed 2025-03-03 | $1.23B 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $303.60M 10-Q · filed 2023-11-09 | $593.80M derived: sum of 2 quarters · filed 2023-11-09 | $882.50M 10-Q · filed 2023-11-09 | $1.22B derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $290.20M 10-Q · filed 2023-08-09 | $578.90M 10-Q · filed 2023-08-09 | $920.80M derived: sum of 3 quarters · filed 2024-02-29 | $1.22B derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $288.70M 10-Q · filed 2023-05-10 | $630.60M derived: sum of 2 quarters · filed 2024-02-29 | $930.80M derived: sum of 3 quarters · filed 2024-02-29 | $1.22B derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $341.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $642.10M derived: sum of 2 quarters · filed 2024-02-29 | $932.30M derived: sum of 3 quarters · filed 2024-02-29 | $1.21B 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $300.20M 10-Q · filed 2022-11-04 | $590.40M derived: sum of 2 quarters · filed 2022-11-04 | $866.40M 10-Q · filed 2022-11-04 | $1.18B derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $290.20M 10-Q · filed 2022-08-05 | $566.20M 10-Q · filed 2022-08-05 | $880.70M derived: sum of 3 quarters · filed 2023-03-01 | $1.14B derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $276.00M 10-Q · filed 2022-05-06 | $590.50M derived: sum of 2 quarters · filed 2023-03-01 | $853.60M derived: sum of 3 quarters · filed 2023-03-01 | $1.09B derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $314.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $577.60M derived: sum of 2 quarters · filed 2023-03-01 | $816.00M derived: sum of 3 quarters · filed 2023-03-01 | $1.05B 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $263.10M 10-Q · filed 2021-11-05 | $501.50M derived: sum of 2 quarters · filed 2021-11-05 | $733.20M 10-Q · filed 2021-11-05 | $1.04B derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $238.40M 10-Q · filed 2021-08-05 | $470.10M 10-Q · filed 2021-08-05 | $773.70M derived: sum of 3 quarters · filed 2022-02-28 | $1.04B derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $231.70M 10-Q · filed 2021-05-10 | $535.30M derived: sum of 2 quarters · filed 2022-02-28 | $802.50M derived: sum of 3 quarters · filed 2022-02-28 | $1.06B derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $303.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $570.80M derived: sum of 2 quarters · filed 2022-02-28 | $830.60M derived: sum of 3 quarters · filed 2022-02-28 | $1.08B 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $267.20M 10-Q · filed 2020-11-06 | $527.00M derived: sum of 2 quarters · filed 2020-11-06 | $773.70M 10-Q · filed 2020-11-06 | $1.05B derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $259.80M 10-Q · filed 2020-08-07 | $506.50M 10-Q · filed 2020-08-07 | $787.30M derived: sum of 3 quarters · filed 2021-03-01 | $1.03B derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $246.70M 10-Q · filed 2020-05-11 | $527.50M derived: sum of 2 quarters · filed 2021-03-01 | $771.50M derived: sum of 3 quarters · filed 2021-03-01 | $1.01B derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $280.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $524.80M derived: sum of 2 quarters · filed 2021-03-01 | $763.30M derived: sum of 3 quarters · filed 2021-03-01 | $995.60M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $244.00M 10-Q · filed 2019-11-04 | $482.50M derived: sum of 2 quarters · filed 2019-11-04 | $714.80M 10-Q · filed 2019-11-04 | $989.10M derived: sum of 4 quarters · filed 2020-03-27 | ||||
| 2018-06-30 | $238.50M 10-Q · filed 2019-08-09 | $470.80M 10-Q · filed 2019-08-09 | $745.10M derived: sum of 3 quarters · filed 2020-03-27 | $981.80M derived: sum of 4 quarters · filed 2020-03-27 | ||||
| 2018-03-31 | $232.30M 10-Q · filed 2019-05-08 | $506.60M derived: sum of 2 quarters · filed 2020-03-27 | $743.30M derived: sum of 3 quarters · filed 2020-03-27 | $973.70M derived: sum of 4 quarters · filed 2020-03-27 | ||||
| 2017-12-31 | $274.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $511.00M derived: sum of 2 quarters · filed 2020-03-27 | $741.40M derived: sum of 3 quarters · filed 2020-03-27 | $949.90M 10-K · filed 2020-03-27 | $952.90M 10-K · filed 2018-03-16 | |||
| 2017-09-30 | $236.70M 10-Q · filed 2018-11-09 | $237.60M 10-Q · filed 2017-11-09 | $467.10M derived: sum of 2 quarters · filed 2018-11-09 | $675.60M 10-Q · filed 2018-11-09 | $677.60M 10-Q · filed 2017-11-09 | $922.70M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $230.40M 10-Q · filed 2018-08-09 | $231.50M 10-Q · filed 2017-08-09 | $438.90M 10-Q · filed 2018-08-09 | $440.00M 10-Q · filed 2017-08-09 | $686.00M derived: sum of 3 quarters · filed 2019-03-01 | $894.70M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $208.50M 10-Q · filed 2018-05-10 | $455.60M derived: sum of 2 quarters · filed 2019-03-01 | $664.30M derived: sum of 3 quarters · filed 2019-03-01 | $865.90M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $247.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $455.80M derived: sum of 2 quarters · filed 2019-03-01 | $657.40M derived: sum of 3 quarters · filed 2019-03-01 | $866.00M 10-K · filed 2019-03-01 | $868.80M 10-K · filed 2017-03-01 | |||
| 2016-09-30 | $208.70M 10-Q · filed 2017-11-09 | $410.30M derived: sum of 2 quarters · filed 2017-11-09 | $618.90M 10-Q · filed 2017-11-09 | $885.60M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $201.60M 10-Q · filed 2017-08-09 | $410.20M 10-Q · filed 2017-08-09 | $676.90M derived: sum of 3 quarters · filed 2018-03-16 | $905.50M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $208.60M 10-Q · filed 2017-05-10 | $475.30M derived: sum of 2 quarters · filed 2018-03-16 | $703.90M derived: sum of 3 quarters · filed 2018-03-16 | $930.50M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $266.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $495.30M derived: sum of 2 quarters · filed 2018-03-16 | $721.90M derived: sum of 3 quarters · filed 2018-03-16 | $915.20M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $228.60M 10-Q · filed 2016-11-09 | $455.20M derived: sum of 2 quarters · filed 2016-11-09 | $648.50M 10-Q · filed 2016-11-09 | $940.70M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $226.60M 10-Q · filed 2016-08-05 | $419.90M 10-Q · filed 2016-08-05 | $712.10M derived: sum of 3 quarters · filed 2017-03-01 | $964.60M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $193.30M 10-Q · filed 2016-05-06 | $485.50M derived: sum of 2 quarters · filed 2017-03-01 | $738.00M derived: sum of 3 quarters · filed 2017-03-01 | $994.90M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $292.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $544.70M derived: sum of 2 quarters · filed 2017-03-01 | $801.60M derived: sum of 3 quarters · filed 2017-03-01 | $1.05B 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $252.50M 10-Q · filed 2015-11-06 | $509.40M derived: sum of 2 quarters · filed 2015-11-06 | $753.40M 10-Q · filed 2015-11-06 | $1.07B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $256.90M 10-Q · filed 2015-08-07 | $500.90M 10-Q · filed 2015-08-07 | $817.10M derived: sum of 3 quarters · filed 2016-02-29 | $1.06B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $244.00M 10-Q · filed 2015-05-08 | $560.20M derived: sum of 2 quarters · filed 2016-02-29 | $806.00M derived: sum of 3 quarters · filed 2016-02-29 | $1.06B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $316.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $562.00M derived: sum of 2 quarters · filed 2016-02-29 | $815.30M derived: sum of 3 quarters · filed 2016-02-29 | $1.03B 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $245.80M 10-Q · filed 2014-11-07 | $499.10M derived: sum of 2 quarters · filed 2014-11-07 | $718.00M 10-Q · filed 2014-11-07 | $993.60M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $253.30M 10-Q · filed 2014-08-08 | $472.20M 10-Q · filed 2014-08-08 | $747.80M derived: sum of 3 quarters · filed 2015-02-27 | $985.50M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $218.90M 10-Q · filed 2014-05-09 | $494.50M derived: sum of 2 quarters · filed 2015-02-27 | $732.20M derived: sum of 3 quarters · filed 2015-02-27 | $964.70M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $275.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $513.30M derived: sum of 2 quarters · filed 2015-02-27 | $745.80M derived: sum of 3 quarters · filed 2015-02-27 | $962.00M 10-K · filed 2015-02-27 | $960.00M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $237.70M 10-Q · filed 2013-11-08 | $237.20M 10-Q · filed 2012-11-08 | $470.20M derived: sum of 2 quarters · filed 2013-11-08 | $686.40M 10-Q · filed 2013-11-08 | $684.90M 10-Q · filed 2012-11-08 | $942.80M derived: sum of 4 quarters · filed 2014-02-27 | ||
| 2012-06-30 | $232.50M 10-Q · filed 2013-08-08 | $447.70M 10-Q · filed 2013-08-08 | $705.10M derived: sum of 3 quarters · filed 2014-02-27 | $934.10M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $215.20M 10-Q · filed 2013-05-09 | $472.60M derived: sum of 2 quarters · filed 2014-02-27 | $701.60M derived: sum of 3 quarters · filed 2014-02-27 | $919.20M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $257.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $486.40M derived: sum of 2 quarters · filed 2014-02-27 | $704.00M derived: sum of 3 quarters · filed 2014-02-27 | $899.20M 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $229.00M 10-Q · filed 2012-11-08 | $446.60M derived: sum of 2 quarters · filed 2012-11-08 | $641.80M 10-Q · filed 2012-11-08 | $861.80M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $217.60M 10-Q · filed 2012-08-09 | $412.80M 10-Q · filed 2012-08-09 | $632.80M derived: sum of 3 quarters · filed 2013-02-28 | $796.50M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $195.20M 10-Q · filed 2012-05-09 | $191.90M 10-Q · filed 2011-05-09 | $415.20M derived: sum of 2 quarters · filed 2013-02-28 | $578.90M derived: sum of 3 quarters · filed 2013-02-28 | $744.50M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2010-12-31 | $220.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $383.70M derived: sum of 2 quarters · filed 2013-02-28 | $549.30M derived: sum of 3 quarters · filed 2013-02-28 | $700.90M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $163.70M 10-Q · filed 2011-11-09 | $329.30M derived: sum of 2 quarters · filed 2011-11-09 | $480.90M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $165.60M 10-Q · filed 2011-08-09 | $317.20M 10-Q · filed 2011-08-09 | ||||||
| 2010-03-31 | $151.40M 10-Q · filed 2011-05-09 | |||||||
| 2009-12-31 | $597.00M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |